[Status of the immune system and the reparative processes in peptic ulcer].

[Possible combination of eosinophilic infiltration of the stomach, small and large intestines with psoriasis]. Arkh Patol (1997) 0.78

[Tramadol in the vascular pains of patients with systemic scleroderma and other rheumatic diseases]. Ter Arkh (1994) 0.78

[Clinical associations of C-reactive protein in systemic sclerosis]. Ter Arkh (2006) 0.77

[Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma]. Ter Arkh (2004) 0.76

[Effect of atropine and methyluracil on gastric mucosal regeneration processes in injuries caused by the administration of acetylsalicyclic acid (aspirin)]. Patol Fiziol Eksp Ter (1980) 0.75

[Reparative characteristics of gastric and duodenal mucosa in ulcer]. Klin Med (Mosk) (1997) 0.75

[The effect of duodenitis on the healing of chronic duodenal ulcers]. Arkh Patol (1975) 0.75

[Pleiotropic effects of statins in systemic sclerosis]. Ter Arkh (2011) 0.75

Diagnosis of occlusive lesions of upper extremity arteries in patients with thromboangiitis obliterans. Angiol Sosud Khir (2003) 0.75

[Effect of vazaprostan on microcirculation in patients with scleroderma systematic]. Ter Arkh (2000) 0.75

[Efficacy and safety of sildenafil in patients with systemic scleroderma]. Ter Arkh (2013) 0.75

[Drug treatment of peptic ulcer]. Ter Arkh (1978) 0.75

[Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori]. Klin Med (Mosk) (1995) 0.75

[Characteristics of the reparative processes in the gastric mucosa in gastroduodenal ulcer]. Arkh Patol (1981) 0.75

[Treatment of uncomplicated peptic ulcers]. Med Sestra (1971) 0.75

[Factors affecting peptic ulcer healing]. Ter Arkh (1979) 0.75

[Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases]. Klin Med (Mosk) (1991) 0.75

[The vasoprostan treatment of patients with Raynaud's syndrome]. Ter Arkh (1997) 0.75

[Clinical value of soluble adhesion molecules in systemic scleroderma]. Klin Med (Mosk) (2003) 0.75

[Biochemical evaluation of reparative processes in duodenal ulcer]. Klin Med (Mosk) (1981) 0.75

[Morphological characteristics of sclerodermic angiopathy]. Arkh Patol (2005) 0.75

[Wide-field capillaroscopy in diagnosis and differential diagnosis of rheumatic diseases]. Ter Arkh (1998) 0.75

[Reparative processes in peptic ulcer (clinico-morphologic study)]. Arkh Patol (1995) 0.75

[Level of soluble tumor necrosis factor receptor type I in patients with systemic scleroderma]. Ter Arkh (2004) 0.75

[Congenital hypoplasia of the pancreas with lipomatosis and bone marrow dysfunction (Shwachman syndrome)]. Arkh Patol (1991) 0.75

[Significance of bone marrow endothelial progenitor cells in disturbance of angiogenesis and endothelial dysfunction in systemic scleroderma]. Vestn Ross Akad Med Nauk (2008) 0.75

[Diet in colitis]. Med Sestra (1966) 0.75

[Efficacy of diet therapy in chronic colitis and enterocolitis]. Vopr Pitan (1968) 0.75

Investigation of sialic acids and sialyltransferase activity in blood of patients with systemic scleroderma. Biochemistry (Mosc) (1999) 0.75

[The rentgenophotometric method of diagnosis of calcium deficiency in chronic enterocolitis]. Sov Med (1969) 0.75

[Characteristics of conservative treatment of stomach ulcer in middle-aged and old persons]. Ter Arkh (1975) 0.75

[Errors in the diagnosis of diseases of the digestive organs]. Ter Arkh (1978) 0.75

[Current concepts of the treatment of patients with peptic ulcer]. Klin Med (Mosk) (1991) 0.75

[Classification of microangiopathy in systemic sclerosis]. Ter Arkh (2005) 0.75

[Visceral manifestations of chronic alcoholism]. Klin Med (Mosk) (1988) 0.75

[Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue]. Ter Arkh (2001) 0.75

[Tumor necrosis factor alpha in systemic scleroderma]. Klin Med (Mosk) (2003) 0.75

[The use of histamine H2-receptor blockaders in the clinical picture of internal diseases]. Farmakol Toksikol (1991) 0.75

[Sprue-like syndrome in systemic scleroderma]. Sov Med (1970) 0.75

[Campylobacter pylori and the reparative processes in peptic ulcer]. Arkh Patol (1990) 0.75

[Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases]. Klin Med (Mosk) (1991) 0.75

[The immune system and regenerative processes]. Klin Med (Mosk) (1991) 0.75

[Alterations of rheological properties of blood in systemic sclerodermia]. Ter Arkh (2002) 0.75

[Mechanism of action of various neurotrophic drugs on reparative processes in injured gastric mucosa]. Patol Fiziol Eksp Ter (1982) 0.75

[Clinico-morphological characteristics of nonspecific reactive hepatitis in chronic enteritis and peptic ulcer]. Klin Med (Mosk) (1987) 0.75

[Diagnostic criteria of pyloric helicobacter infection in peptic ulcer]. Arkh Patol (1993) 0.75

[Functional status of the liver in chronic colitis and enterocolitis determined by the absorption of I 131-labelled rose bengal]. Sov Med (1967) 0.75

[Adhesion molecules in systemic scleroderma]. Ter Arkh (2003) 0.75

[Clinico-immunologic characteristics of peptic ulcer]. Klin Med (Mosk) (1988) 0.75

[Mechanisms of disturbance in the digestive glands' secretory function in patients with chronic colitis and enterocolitis]. Sov Med (1970) 0.75

[Vascular pathology in systemic scleroderma]. Vestn Ross Akad Med Nauk (2003) 0.75

[Enteropathic amyloidosis: clinical features, place among other forms of amyloidosis]. Klin Med (Mosk) (2000) 0.75

[Use of prodigiozan in chronic diseases of intestine]. Antibiotiki (1969) 0.75

[Mineral metabolism and the functional status of the adrenal cortex in chronic enterocolitis]. Sov Med (1969) 0.75

[Angiogenesis and its association with inflammation and fibrosis in course of the development of scleroderma systematica]. Arkh Patol (2015) 0.75

[Prolactin levels in patients with systemic scleroderma]. Klin Med (Mosk) (1998) 0.75